Acteoside treatment in LPS-induced SALI mouse model

Validation Score: 0.900 Price: $0.50 sepsis-associated acute lung injury LPS-induced SALI mouse model Status: proposed

What This Experiment Tests

Validation experiment designed to validate causal mechanisms targeting Nrf2 in LPS-induced SALI mouse model. Primary outcome: histological damage, pulmonary edema, inflammatory cell infiltration

Description

This experiment investigated the protective effects of acteoside, a plant-derived phenylethanoid glycoside, against sepsis-associated acute lung injury (SALI) using an LPS-induced mouse model. The study examined whether acteoside could alleviate lung injury by targeting ferroptosis, an iron-dependent cell death process. Researchers evaluated histological changes, pulmonary edema, inflammatory cell infiltration, and various biomarkers of inflammation and ferroptosis. The experiment involved treating mice with LPS to induce SALI, followed by acteoside administration, and then assessing lung tissue damage, inflammatory mediator levels (TNF-α, IL-6, IL-1β, IFN-β), and ferroptosis-related parameters including antioxidant enzyme activities (SOD/GSH), oxidative stress markers (iron, GSSG, 4-HNE, MDA), and expression of key ferroptosis-related proteins (SLC7A11, GPX4, Nrf2, ACSL4, TfR1, PTGS2).

TARGET GENE
Nrf2
MODEL SYSTEM
LPS-induced SALI mouse model
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
ferroptosis pathway, Nrf2 signaling
SOURCE
extracted_from_pmid_41895086
PRIMARY OUTCOME
histological damage, pulmonary edema, inflammatory cell infiltration

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

NRF2 Activator Therapy for NeurodegenerationtherapeuticNRF2 Activator TherapyideaNRF2 — Nuclear Factor Erythroid 2-Related Factor 2proteinnrf2-activators-parkinsons-diseasetherapeuticNRF2 Therapeutics: Investment Landscape AnalysisinvestmentNRF2 Activators for Parkinson's DiseasemechanismNRF2-KEAP1 Oxidative Stress Response PathwaymechanismNRF2 Signaling Pathway in NeurodegenerationmechanismNRF2 Activators in Neurodegenerative DiseasetherapeuticNRF2 GenegeneNRF2 Oxidative Stress PathwaymechanismTNF GenegeneTNF - Tumor Necrosis FactorgeneACSL4 Inhibition for Ferroptosis Prevention in NeuideaGPX4 Gene - Glutathione Peroxidase 4gene

Protocol

LPS injection to induce SALI, acteoside treatment, histological analysis, measurement of inflammatory mediators, assessment of ferroptosis biomarkers

Expected Outcomes

acteoside reduces lung injury, inflammation, and ferroptosis markers

Success Criteria

reduced histological damage, decreased inflammatory mediators, improved antioxidant status, normalized ferroptosis-related protein expression

Related Hypotheses (1)

Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling0.544

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.